← Back to patent-cliff list

CAS 1072-98-6

5-chloropyridin-2-amine

Codes: BETR-002, ETOR-001, AQW-051-001

Application context (from source-drug indications)

Venous thromboembolismBetrixabanHepatic function declineBetrixabanAtrial fibrillationBetrixabanAtrial flutterBetrixabanRenal impairmentBetrixabanThromboembolismBetrixabanOsteoarthritisEtoricoxib痛风性关节炎EtoricoxibDysmenorrhoeaEtoricoxibRheumatoid arthritisEtoricoxibAnkylosing spondylitisEtoricoxibParkinson's diseaseEtoricoxibAnxietyAQW-051表现焦虑AQW-051Alzheimer's diseaseAQW-051Mild cognitive impairmentAQW-051SchizophreniaAQW-051运动障碍AQW-051

Source drugs (routes using this intermediate)

DrugTierExpiry
BetrixabanTier C — Watch / trade2028
EtoricoxibTier C — Watch / trade-
AQW-051Tier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.